首页 | 本学科首页   官方微博 | 高级检索  
检索        

凝血酶激活的纤溶抑制物与肺部疾病的关系
引用本文:蒋晨成,孔英君,李世敏.凝血酶激活的纤溶抑制物与肺部疾病的关系[J].国际呼吸杂志,2014,34(24):1895-1899.
作者姓名:蒋晨成  孔英君  李世敏
作者单位:150001,哈尔滨医科大学附属第一医院呼吸内科二病房
摘    要:凝血酶激活的纤溶抑制物是近年发现的血浆羧肽酶原,在调节血浆凝块的纤溶过程中有着重要的作用,而最近研究发现,其生理功能并不限于控制纤溶系统,还有更广泛的抗炎作用.现就凝血酶激活的纤溶抑制物与肺血栓栓塞症、ALI、肺间质纤维化、支气管哮喘等肺部疾病的相关性作一综述.

关 键 词:凝血酶激活的纤溶抑制物  肺间质纤维化  肺血栓栓塞症  支气管哮喘

Relationship of thrombin-activatable fibrinolysis inhibitor with lung diseases
Jiang Chencheng,Kong Yingjun,Li Shimin.Relationship of thrombin-activatable fibrinolysis inhibitor with lung diseases[J].International Journal of Respiration,2014,34(24):1895-1899.
Authors:Jiang Chencheng  Kong Yingjun  Li Shimin
Institution:.Department of Respiratory Medicine, the First Affiliated Hospital of Harbin Medical University, Harbin 150001 ,China
Abstract:Thrombin-activatable fibrinolysis inhibitor is a recently discovered plasma enzyme,that plays an important role in the fibrinolytic system.Recent studies suggest that its physiological function is not limited to controlling fibrinolysis but may serve a much broader anti-inflammatory role.The article reviews the association of thrombin-activatable fibrinolysis inhibitor and lung diseases,such as acute lung injury,pulmonary fibrosis,pulmonary thromboembolism,and bronchial asthma.
Keywords:Thrombin-activatable fibrinolysis inhibitor  Pulmonary fibrosis  Pulmonary thromboembolism  Bronchial asthma
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号